CT388-103 was a multi-center, randomized, double-blind, placebo-controlled, parallel-group, dose-finding Phase II study conducted in 469 adults with obesity or who are overweight and have at least one weight-related comorbidity, excluding type 2 diabetes
Many patients dont realize these medications are FDA-approved for preventing heart disease
Clin Transl Med 11:e382 Yang W, Wang Y, Zhang C, Huang Y, Yu J, Shi L, Zhang P, Yin Y, Li R, Tao K (2022) Maresin1 protect against ferroptosis-induced liver injury through ros inhibition and nrf2/ho-1/gpx4 activation
Monitor Your Skin: Keep a close eye on your skins condition after starting glutathione supplementation
Insurance coverage varies across carriers like Aetna, Blue Cross Blue Shield, UnitedHealthcare, and more
& Hsiao, F